Literature DB >> 18832718

Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing.

Rachel E Sutherland1, Joanna S Olsen, Andrew McKinstry, S Armando Villalta, Paul J Wolters.   

Abstract

The pleiotropic cytokine IL-6 has favorable and harmful effects on survival from bacterial infections. Although many innate immune cells produce IL-6, little is known about relevant sources in vivo and the nature of its contributions to host responses to severe bacterial infections. To examine these roles, we subjected mast cell-specific IL-6-deficient mice to the cecal ligation and puncture model of septic peritonitis, finding that survival in these mice is markedly worse than in controls. Following intranasal or i.p. inoculation with Klebsiella pneumoniae, IL-6 (-/-) mice are less likely to survive than wild-type controls and at the time of death have higher numbers of bacteria but not inflammatory cells in lungs and peritoneum. Similarly, mast cell-specific IL-6-deficient mice have diminished survival and higher numbers of K. pneumoniae following i.p. infection. Neutrophils lacking IL-6 have greater numbers of live intracellular K. pneumonia, suggesting impaired intracellular killing contributes to reduced clearance in IL-6(-/-) mice. These results establish that mast cell IL-6 is a critical mediator of survival following K. pneumoniae infection and sepsis and suggest that IL-6 protects from death by augmenting neutrophil killing of bacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832718      PMCID: PMC2610024          DOI: 10.4049/jimmunol.181.8.5598

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.

Authors:  M Plaut; J H Pierce; C J Watson; J Hanley-Hyde; R P Nordan; W E Paul
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

2.  Mouse bone marrow-derived IL-3-dependent mast cells and autonomous sublines produce IL-6.

Authors:  L Hültner; H Szöts; M Welle; J Van Snick; J Moeller; P Dörmer
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

Review 3.  Interleukin-6 in biology and medicine.

Authors:  S Akira; T Taga; T Kishimoto
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

4.  Mast cell phagocytosis of FimH-expressing enterobacteria.

Authors:  R Malaviya; E A Ross; J I MacGregor; T Ikeda; J R Little; B A Jakschik; S N Abraham
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

5.  Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.

Authors:  P Bradding; J A Roberts; K M Britten; S Montefort; R Djukanovic; R Mueller; C H Heusser; P H Howarth; S T Holgate
Journal:  Am J Respir Cell Mol Biol       Date:  1994-05       Impact factor: 6.914

6.  c-kit Gene was not transcribed in cultured mast cells of mast cell-deficient Wsh/Wsh mice that have a normal number of erythrocytes and a normal c-kit coding region.

Authors:  T Tono; T Tsujimura; U Koshimizu; T Kasugai; S Adachi; K Isozaki; S Nishikawa; M Morimoto; Y Nishimune; S Nomura
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

7.  Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice.

Authors:  L R Leon; A A White; M J Kluger
Journal:  Am J Physiol       Date:  1998-07

8.  Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.

Authors:  E Razin; J N Ihle; D Seldin; J M Mencia-Huerta; H R Katz; P A LeBlanc; A Hein; J P Caulfield; K F Austen; R L Stevens
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

9.  Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.

Authors:  J R Gordon; S J Galli
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

10.  Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines.

Authors:  P R Burd; H W Rogers; J R Gordon; C A Martin; S Jayaraman; S D Wilson; A M Dvorak; S J Galli; M E Dorf
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  66 in total

Review 1.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

Review 2.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

3.  Dipeptidyl peptidase I controls survival from Klebsiella pneumoniae lung infection by processing surfactant protein D.

Authors:  Rachel E Sutherland; Sophia S Barry; Joanna S Olsen; D Brenda Salantes; George H Caughey; Paul J Wolters
Journal:  Biochem Biophys Res Commun       Date:  2014-06-21       Impact factor: 3.575

4.  Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.

Authors:  Daniel E Dulek; Dawn C Newcomb; Kasia Goleniewska; Jaqueline Cephus; Weisong Zhou; Sara Reiss; Shinji Toki; Fei Ye; Rinat Zaynagetdinov; Taylor P Sherrill; Timothy S Blackwell; Martin L Moore; Kelli L Boyd; Jay K Kolls; R Stokes Peebles
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

5.  Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice.

Authors:  Eric J Seeley; Rachel E Sutherland; Sophia S Kim; Paul J Wolters
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

6.  Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions.

Authors:  N M Michels; H W Chu; S C LaFasto; S R Case; M N Minor; R J Martin
Journal:  Clin Exp Allergy       Date:  2010-03-23       Impact factor: 5.018

Review 7.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

8.  Inhibitory effects of methamphetamine on mast cell activation and cytokine/chemokine production stimulated by lipopolysaccharide in C57BL/6J mice.

Authors:  Li Xue; Yan Geng; Ming Li; Yao-Feng Jin; Hui-Xun Ren; Xia Li; Feng Wu; Biao Wang; Wei-Ying Cheng; Teng Chen; Yan-Jiong Chen
Journal:  Exp Ther Med       Date:  2018-02-05       Impact factor: 2.447

9.  The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis.

Authors:  Adrian M Piliponsky; Ching-Cheng Chen; Eon J Rios; Piper M Treuting; Asha Lahiri; Magnus Abrink; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

10.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.